As of Apr 28
| +0.30 / +0.25%|
The 9 analysts offering 12-month price forecasts for GW Pharmaceuticals PLC have a median target of 160.00, with a high estimate of 208.00 and a low estimate of 55.00. The median estimate represents a +34.76% increase from the last price of 118.73.
The current consensus among 9 polled investment analysts is to Buy stock in GW Pharmaceuticals PLC. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.